Siemens Latest Hemostasis Products Offer Enhanced Sensitivity And Efficiency In Calibration And Quality Control

Siemens Healthcare Diagnostics has launched the new INNOVANCE Antithrombin assay kit featuring ready-to-use, all-liquid reagents and a human factor Xa substrate to offer higher levels of sensitivity in the diagnosis of antithrombin deficiencies. The chromogenic, automated INNOVANCE Antithrombin test is designed for use on Siemens BCS/BCS XP and Sysmex CA-500 Series, CA-1500 and CA-7000 Systems.

Additionally, Siemens new Berichrom Heparin Unfractionated and Low Molecular Weight Calibrators and Controls now offers a complete solution for monitoring heparin with the Berichrom Heparin assay. Berichrom Heparin Calibrators and Controls are traceable to World Health Organization (WHO) standards and are assigned calibration values that are consistent across all Siemens BCS/BCS XP and Sysmex CA-500 Series, CA-1500 and CA-7000 hemostasis Systems. Siemens unique Quality Assurance Program for heparin controls also enables customers to compare their control performance to that of their peers.

About The Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For more information, visit www.siemens.com/healthcare.

SOURCE: Siemens